Table 1.
Clinical characteristics of people with type 2 diabetes with or without a prescription of SGLT-2i
| Characteristic | T2DM prescribed SGLT-2i (N = 26,700) |
T2DM not prescribed SGLT-2i (N = 215,924) |
|---|---|---|
| Age (years) | 59.8 ± 10.9 | 67.5 ± 13.9 |
| Male | 15,680 (58.7) | 118,958 (55.1) |
| Ethnicity | ||
| White | 17,735 (66.4) | 142,664 (66.1) |
| Asian | 3369 (12.6) | 23,559 (10.9) |
| Black | 804 (3.0) | 8924 (4.1) |
| Mixed | 210 (0.8) | 1752 (0.8) |
| Other | 279 (1.0) | 2090 (1.0) |
| Missing | 4303 (16.1) | 36,935 (17.1) |
| IMD quintile | ||
| IMD quintile 5 (least deprived) | 4984 (18.7) | 44,284 (20.5) |
| IMD quintile 4 | 5249 (19.7) | 44,301 (20.5) |
| IMD quintile 3 | 5063 (19.0) | 41,355 (19.2) |
| IMD quintile 2 | 4873 (18.3) | 38,448 (17.8) |
| IMD quintile 1 (most deprived) | 5774 (21.6) | 41,227 (19.1) |
| Missing | 757 (2.8) | 6309 (2.9) |
| Duration of diabetes (years) | 9.4 ± 6.3 | 9.3 ± 7.3 |
| < 1 | 1582 (5.9) | 16,019 (7.4) |
| 1–4 | 5686 (21.3) | 56,009 (25.9) |
| 5–9 | 8187 (30.7) | 58,595 (27.1) |
| ≥ 10 | 11,245 (42.1) | 85,301 (39.5) |
Data are presented as n (%) or mean (± SD)
IMD Index of Multiple Deprivation, SGLT-2i sodium–glucose co‐transporter‐2 inhibitor, T2DM Type 2 diabetes